Publications by authors named "OEydis Hide"

Background: Type I allergy to sweat is involved in the pathogenesis of atopic dermatitis (AD) and cholinergic urticaria (CholU), with MGL_1304 from Malassezia globosa being the major causative antigen. Currently, no standard diagnostic test exists for sweat allergy that uses serum.

Methods: The ImmunoCAP (iCAP) system to measure antigen-specific IgE was developed using recombinant MGL_1304 (rMGL_1304).

View Article and Find Full Text PDF
Article Synopsis
  • The 2024 clinical practice guidelines for atopic dermatitis (AD) focus on effectively managing this condition characterized by itchy, relapsing eczema.
  • The primary goal of treatment is to quickly induce remission by reducing skin inflammation and itching, primarily using topical anti-inflammatory medications.
  • The updated guidelines introduce five new treatments and emphasize the importance of evaluating research and weighing the pros and cons of various medical options to enhance patient outcomes.
View Article and Find Full Text PDF

Objectives: An update of the first European Society of Musculoskeletal Radiology (ESSR) consensus on soft tissue tumor imaging in 2015 became necessary due to technical advancements, further insights into specific entities, and the revised WHO classification (2020) and AJCC staging system (2017). The third part of the revised guidelines covers algorithms and techniques beyond initial imaging: (1) Imaging after neoadjuvant therapy in soft tissue sarcoma, (2) sarcoma surveillance, and (3) special aspects, including surveillance of non-malignant entities and the role of interventional radiology.

Materials And Methods: A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GB) is highly invasive, and the study investigates the origins and molecular characteristics of butterfly glioblastoma (bGB) by analyzing a cohort of 34 bGB patients alongside others from public datasets.
  • The results show that bGB can arise from two distinct origins—corpus callosum (CC) and cerebral hemisphere—with unique molecular mutations and prognostic implications, particularly identifying the CC-type as having worse survival outcomes.
  • The study emphasizes the need for further research to understand the clinical significance and differences between the identified bGB subtypes to enhance treatment strategies and patient care.
View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) poses significant treatment challenges, particularly targeting amyloid-β (Aβ), but a new analysis method uncovered 83 dysfunctional pathways relevant to AD in both human brains and lab models.
  • The p38 MAPK pathway was notably upregulated and linked to tau pathology and neuronal damage, highlighting its potential as a therapeutic target.
  • By using integrative pathway activity analysis (IPAA), researchers can combine human data with cellular models to efficiently identify promising drug targets for AD treatment.*
View Article and Find Full Text PDF

Objectives: In this study, we introduce an intervention based on two techniques: twang and medialization. The hypothesis is that a combination of these two techniques will enable trans women to gain feminine-sounding speech without vocal strain or harm.

Method: Five trans women took part in the study.

View Article and Find Full Text PDF

Melioidosis is a neglected tropical disease caused by Burkholderia pseudomallei, endemic to Southeast Asia and Northern Australia. Despite its increasing global public health and clinical significance, the molecular epidemiology of melioidosis and genetic diversity of B. pseudomallei in Cambodia remains poorly understood.

View Article and Find Full Text PDF

Chronic spontaneous urticaria (CSU) is a typical example of an intractable skin disease with no clear cause and significantly affects daily life of patients. Because CSU is a human-specific disease and lacks proper animal model, there are many questions regarding its pathophysiological dynamics. On the other hand, most clinical symptoms of urticaria are notable as dynamic appearance of skin eruptions called wheals.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic spontaneous urticaria (CSU) shows a good response to omalizumab (OMA), but patients who don't respond well need a closer look at their long-term prognosis and treatment options.
  • A study analyzed 48 patients who received three doses of OMA and tracked their progress over 12 months, finding that 28 had a good prognosis, while 20 had a less favorable outcome.
  • Key factors linked to better outcomes included shorter CSU duration, presence of angioedema, low IgE levels pre-treatment, increased eosinophils after treatment, and higher urticaria control test scores; using immunosuppressants also predicted a better prognosis, while corticosteroids had a negative impact.
View Article and Find Full Text PDF
Article Synopsis
  • CRUSE® is an app designed for people with chronic spontaneous urticaria (CSU) to track their symptoms using visual analogue scales (VASs), aiming to assess the app's effectiveness in measuring disease activity.
  • A study analyzed three VASs related to CSU impact on daily life, including one specifically for the severity of urticaria, one for productivity, and a general health measure (EQ-5D), using data from nearly 6,000 patients over many days.
  • The results showed that the CRUSE® app's VASs demonstrate strong validity and reliability, with the "VAS urticaria" being most effective in capturing symptom changes, while the minimal important difference (MID) values indicated meaningful changes
View Article and Find Full Text PDF

Background: Trichomoniasis caused by Trichomonas vaginalis is the most prevalent nonviral sexually transmitted disease in women and has frequently damaged public health. To better use the animal model and take a step forward fully elucidating this pathogen, intraperitoneal infection of T. vaginalis in mice, one of the most common mouse models, was highly concerned.

View Article and Find Full Text PDF
Article Synopsis
  • Long-term effectiveness and safety of omalizumab for Chronic Inducible Urticaria (CIndU) were evaluated in a large cohort across 14 specialized centers, revealing it to be highly effective for most patients.
  • Out of 234 patients, 73% reported significant improvements while the median treatment duration exceeded 5 years, mainly due to disease control.
  • Patient age was a predictor of treatment continuation, with older patients less likely to discontinue due to well-controlled disease, and CIndU subtype did not impact treatment response or duration.
View Article and Find Full Text PDF
Article Synopsis
  • Calphostin C (Cal-C) is a known protein kinase C (PKC) inhibitor that can inhibit PKC activation at low concentrations but activate it at high concentrations through a light-dependent mechanism.
  • At low doses (<200 nM), Cal-C successfully stops PKC translocation and activation induced by certain compounds, while at higher doses (>2 μM), it raises intracellular calcium levels by mobilizing the endoplasmic reticulum (ER) without involving specific receptors.
  • The study also found that high concentrations of Cal-C cause structural changes in the ER and generate singlet oxygen, which contributes to PKC activation and indicates its potential use in photodynamic therapy.
View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether a standard dose of bilastine (20 mg) is as effective as a double dose of second-generation H1-antihistamines for treating patients with refractory chronic spontaneous urticaria (CSU).
  • Conducted as a phase IV, multicenter trial, it involved 128 patients and measured treatment efficacy through the mean total symptom score (TSS) after 5-7 days of administration.
  • Results showed that bilastine was non-inferior in effectiveness to double-dose H1AH and had a similar safety profile, with no serious adverse effects reported in either treatment group.
View Article and Find Full Text PDF
Article Synopsis
  • Urticaria is a skin condition where raised bumps (wheals) appear and usually go away within a day or two.
  • A 58-year-old man experienced itchy, red, ring-shaped spots for about two months, which got bigger but then disappeared after several days.
  • After trying different medications without improvement, he finally felt better after taking a steroid and another medication, and the rash didn’t come back after stopping all treatments.
View Article and Find Full Text PDF
Article Synopsis
  • In Japan, a study was conducted on the safety and efficacy of ligelizumab, an anti-IgE monoclonal antibody, for treating chronic spontaneous urticaria (CSU) in patients who weren't responding well to H1-antihistamines.
  • The study, which included 66 adult participants, showed that while 80.3% experienced mild to moderate side effects, there were no severe adverse events or anaphylaxis, and only 6.1% stopped treatment due to side effects.
  • Significant improvements were noted: UAS7 scores improved quickly by Week 4 and continued to improve by Week 52, with 50% of patients achieving no symptoms, and a notable increase in quality of life
View Article and Find Full Text PDF
Article Synopsis
  • * This study investigated the use of focused shock waves to non-invasively release tumor-associated antigens from renal carcinoma cell lines, resulting in significant decreases in specific antigens on the cell surface.
  • * Findings indicated that the shock waves and cavitation led to antigen release into extracellular spaces, with theoretical models developed to understand the mechanisms and cellular responses involved in this process.
View Article and Find Full Text PDF
Article Synopsis
  • Hereditary angioedema (HAE) significantly impacts patients' quality of life, and understanding the disease burden is crucial for effective treatment.
  • In 2021, patient-reported outcome measures (PROMs) showed that higher attack frequencies correlated with increased health-related quality of life (HRQoL) impairment.
  • The study highlighted that patients experiencing more frequent HAE attacks had notable difficulties in work productivity, experiencing both absenteeism and presenteeism.
View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a chronic skin disease characterized by intense itching, and new treatments like dupilumab have been developed but predicting the right treatment for each patient is challenging.
  • A study involving 110 AD patients aimed to identify factors and biomarkers that could indicate how well patients might respond to dupilumab, using various scales for assessment.
  • Findings showed that higher baseline serum LDH levels and certain comorbidities, like food allergies, were linked to poorer treatment outcomes, suggesting these could help guide treatment decisions for AD patients.
View Article and Find Full Text PDF

Cancer cells edit gene expression to evade immunosurveillance. However, genome-wide studies of gene editing during early tumorigenesis are lacking. Here we used single-cell RNA sequencing in a breast cancer genetically engineered mouse model (GEMM) to identify edited genes without bias.

View Article and Find Full Text PDF

Background: Craniotomy is required for the removal of brainstem cavernous malformations (CMs) with repeated hemorrhage, and this condition is often complicated by an accompanying developmental venous anomaly (DVA). However, a DVA of the brainstem or cerebellum with drainage penetrating the pons is an exceptional finding.

Observations: A 57-year-old man presented with double vision.

View Article and Find Full Text PDF

The gut microbiota has been demonstrated to play a significant role in the pathogenesis of Parkinson's disease (PD). However, conflicting findings regarding specific microbial species have been reported, possibly due to confounding factors within human populations. Herein, our current study investigated the interaction between the gut microbiota and host in a non-human primate (NHP) PD model induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using a multi-omic approach and a self-controlled design.

View Article and Find Full Text PDF

Objectives: The revised European Society of Musculoskeletal Radiology (ESSR) consensus guidelines on soft tissue tumor imaging represent an update of 2015 after technical advancements, further insights into specific entities, and revised World Health Organization (2020) and AJCC (2017) classifications. This second of three papers covers algorithms once histology is confirmed: (1) standardized whole-body staging, (2) special algorithms for non-malignant entities, and (3) multiplicity, genetic tumor syndromes, and pitfalls.

Materials And Methods: A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries.

View Article and Find Full Text PDF

Importance: Treating patients with chronic urticaria using omalizumab has been shown to be safe and effective in randomized clinical trials. Multinational studies on long-term omalizumab performance in chronic urticaria in clinical practice settings are lacking, especially on drug survival. Drug survival, which refers to the length of time that patients are treated with a specific drug, is a comprehensive outcome covering effectiveness, safety, and patient and physician preferences.

View Article and Find Full Text PDF